Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Sponsored by DeGette, Diana (Democrat-CO-1) · House · Introduced May 14, 2026
AI-assisted analysis: Summaries and rider analysis are generated using AI and reviewed for accuracy. This tool is for informational purposes only. Always verify with official sources before making decisions.Learn about our methodology.
Plain-English Summary (AI-assisted)
This is a nonbinding resolution expressing the House's position that mifepristone (a medication used for abortion) should be regulated based on scientific evidence showing it is safe and effective, and that abortion medication access should be equitable and transparent. The resolution does not create, change, or enforce any laws.
Legislative Status Timeline
Introduced
May 14, 2026
In Committee
May 14, 2026
Passed House
Pending
Passed Senate
Pending
Presidential Action
Pending
Sponsor
DeGette, Diana
Independent · CO-1
Want to know when this bill's status changes?
Get notified about 119-hres-1285 and other CO legislation.